{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:10:23Z","timestamp":1790809823782,"version":"4.1.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T00:00:00Z","timestamp":1266364800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00417-010-1307-z","type":"journal-article","created":{"date-parts":[[2010,2,16]],"date-time":"2010-02-16T11:04:42Z","timestamp":1266318282000},"page":"613-626","source":"Crossref","is-referenced-by-count":62,"title":["Verteporfin PDT for non-standard indications\u2014a review of current literature"],"prefix":"10.1007","volume":"248","author":[{"given":"Wai Man","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tock-Han","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Pece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufino","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagahisa","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,17]]},"reference":[{"key":"1307_CR1","first-page":"198","volume":"119","author":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group","year":"2001","unstructured":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP Report 2. Arch Ophthalmol 119:198\u2013207","journal-title":"Arch Ophthalmol"},{"key":"1307_CR2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0161-6420(02)01998-X","volume":"110","author":"Verteporfin In Photodynamic Therapy (VIP) Study Group","year":"2003","unstructured":"Verteporfin In Photodynamic Therapy (VIP) Study Group (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP Report No. 3. Ophthalmology 110:667\u2013673","journal-title":"Ophthalmology"},{"key":"1307_CR3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.preteyeres.2005.01.001","volume":"24","author":"RA Costa","year":"2005","unstructured":"Costa RA, Navajas EV, Farah ME, Calucci D, Cardillo JA, Scott IU (2005) Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm. Prog Retin Eye Res 24:560\u2013586","journal-title":"Prog Retin Eye Res"},{"key":"1307_CR4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0002-9394(02)01404-6","volume":"133","author":"M Uyama","year":"2002","unstructured":"Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H, Fukushima I, Takahashi K, Matsumura M (2002) Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 133:639\u2013648","journal-title":"Am J Ophthalmol"},{"key":"1307_CR5","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.121.10.1392","volume":"121","author":"K Sho","year":"2003","unstructured":"Sho K, Takahashi K, Yamada H, Wada M, Nagai Y, Otsuji T, Nishikawa M, Mitsuma Y, Yamazaki Y, Matsumura M, Uyama M (2003) Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 121:1392\u20131396","journal-title":"Arch Ophthalmol"},{"key":"1307_CR6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ophtha.2007.02.031","volume":"115","author":"F Gomi","year":"2008","unstructured":"Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, Ikuno Y, Tano Y (2008) One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 115:141\u2013146","journal-title":"Ophthalmology"},{"key":"1307_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","volume":"144","author":"I Maruko","year":"2007","unstructured":"Maruko I, Iida T, Saito M, Nagayama D, Saito K (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144:15\u201322","journal-title":"Am J Ophthalmol"},{"key":"1307_CR8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.survophthal.2003.10.007","volume":"49","author":"AP Ciardella","year":"2004","unstructured":"Ciardella AP, Donsoff IM, Huang SJ, Costa DL, Yannuzzi LA (2004) Polypoidal choroidal vasculopathy. Surv Ophthalmol 49:25\u201337","journal-title":"Surv Ophthalmol"},{"key":"1307_CR9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s10384-007-0452-3","volume":"51","author":"E Akaza","year":"2007","unstructured":"Akaza E, Yuzawa M, Matsumoto Y, Kashiwakura S, Fujita K, Mori R (2007) Role of photodynamic therapy in polypoidal choroidal vasculopathy. Jpn J Ophthalmol 51:270\u2013277","journal-title":"Jpn J Ophthalmol"},{"key":"1307_CR10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/IAE.0b013e31816577cb","volume":"28","author":"E Akaza","year":"2008","unstructured":"Akaza E, Mori R, Yuzawa M (2008) Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy. Retina 28:717\u2013722","journal-title":"Retina"},{"key":"1307_CR11","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.ophtha.2003.12.056","volume":"111","author":"WM Chan","year":"2004","unstructured":"Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y, Wong TH (2004) Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology 111:1576\u20131584","journal-title":"Ophthalmology"},{"key":"1307_CR12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ajo.2009.02.012","volume":"148","author":"M Cho","year":"2009","unstructured":"Cho M, Barbazetto IA, Freund KB (2009) Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy. Am J Ophthalmol 148:70\u201378","journal-title":"Am J Ophthalmol"},{"key":"1307_CR13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ajo.2008.05.025","volume":"146","author":"Y Kurashige","year":"2008","unstructured":"Kurashige Y, Otani A, Sasahara M, Yodoi Y, Tamura H, Tsujikawa A, Yoshimura N (2008) Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 146:513\u2013519","journal-title":"Am J Ophthalmol"},{"key":"1307_CR14","first-page":"1417","volume":"23","author":"MW Lee","year":"2008","unstructured":"Lee MW, Yeo I, Wong D, Ang CL (2008) Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy. Eye 23:1417\u20131422","journal-title":"Eye"},{"key":"1307_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000076844","volume":"218","author":"SC Lee","year":"2004","unstructured":"Lee SC, Seong YS, Kim SS, Koh HJ, Kwon OW (2004) Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula. Ophthalmologica 218:193\u2013201","journal-title":"Ophthalmologica"},{"key":"1307_CR16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2007.03.014","volume":"144","author":"A Otani","year":"2007","unstructured":"Otani A, Sasahara M, Yodoi Y, Aikawa H, Tamura H, Tsujikawa A, Yoshimura N (2007) Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 144:7\u201314","journal-title":"Am J Ophthalmol"},{"key":"1307_CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2152\/jmi.55.231","volume":"55","author":"S Matsushita","year":"2008","unstructured":"Matsushita S, Naito T, Takebayashi M, Sato H, Shiota H (2008) The prognosis of cases with massive subretinal hemorrhage after photodynamic therapy. J Med Invest 55:231\u2013235","journal-title":"J Med Invest"},{"key":"1307_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.eye.6702996","volume":"23","author":"Y Mitamura","year":"2009","unstructured":"Mitamura Y, Kubota-Taniai M, Okada K, Kitahashi M, Baba T, Mizunoya S, Yamamoto S (2009) Comparison of photodynamic therapy to transpupillary thermotherapy for polypoidal choroidal vasculopathy. Eye 23:67\u201372","journal-title":"Eye"},{"key":"1307_CR19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/IAE.0b013e31804b3f70","volume":"27","author":"CM Eandi","year":"2007","unstructured":"Eandi CM, Ober MD, Freund KB, Slakter JS, Yannuzzi LA (2007) Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization. Retina 27:825\u2013831","journal-title":"Retina"},{"key":"1307_CR20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10384-008-0582-2","volume":"52","author":"K Yamashiro","year":"2008","unstructured":"Yamashiro K, Tsujikawa A, Nishida A, Mandai M, Kurimoto Y (2008) Recurrence of polypoidal choroidal vasculopathy after photodynamic therapy. Jpn J Ophthalmol 52:457\u2013462","journal-title":"Jpn J Ophthalmol"},{"key":"1307_CR21","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/IAE.0b013e3181a3b7c5","volume":"29","author":"D Tsuchiya","year":"2009","unstructured":"Tsuchiya D, Yamamoto T, Kawasaki R, Yamashita H (2009) Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions. Retina 29:960\u2013965","journal-title":"Retina"},{"key":"1307_CR22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10384-007-0501-y","volume":"52","author":"WK Lee","year":"2008","unstructured":"Lee WK, Lee PY, Lee SK (2008) Photodynamic therapy for polypoidal choroidal vasculopathy: vaso-occlusive effect on the branching vascular network and origin of recurrence. Jpn J Ophthalmol 52:108\u2013115","journal-title":"Jpn J Ophthalmol"},{"key":"1307_CR23","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bjo.2007.132357","volume":"92","author":"T Wakabayashi","year":"2008","unstructured":"Wakabayashi T, Gomi F, Sawa M, Tsujikawa M, Tano Y (2008) Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy. Br J Ophthalmol 92:936\u2013940","journal-title":"Br J Ophthalmol"},{"key":"1307_CR24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.iae.0000233647.78726.46","volume":"27","author":"Y Hirami","year":"2007","unstructured":"Hirami Y, Tsujikawa A, Otani A, Yodoi Y, Aikawa H, Mandai M, Yoshimura N (2007) Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy. Retina 27:335\u2013341","journal-title":"Retina"},{"key":"1307_CR25","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ajo.2005.12.002","volume":"141","author":"Y Ojima","year":"2006","unstructured":"Ojima Y, Tsujikawa A, Otani A, Hirami Y, Aikawa H, Yoshimura N (2006) Recurrent bleeding after photodynamic therapy in polypoidal choroidal vasculopathy. Am J Ophthalmol 141:958\u2013960","journal-title":"Am J Ophthalmol"},{"key":"1307_CR26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00006982-200210000-00001","volume":"22","author":"RF Spaide","year":"2002","unstructured":"Spaide RF, Donsoff I, Lam DL, Yannuzzi LA, Jampol LM, Slakter J, Sorenson J, Freund KB (2002) Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. Retina 22:529\u2013535","journal-title":"Retina"},{"key":"1307_CR27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00417-005-1139-4","volume":"243","author":"RM Silva","year":"2005","unstructured":"Silva RM, Figueira J, Cachulo ML, Duarte L, Faria dA Jr, Cunha-Vaz JG (2005) Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 243:973\u2013979","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1307_CR28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","volume":"86","author":"M Wang","year":"2008","unstructured":"Wang M, Munch IC, Hasler PW, Prunte C, Larsen M (2008) Central serous chorioretinopathy. Acta Ophthalmol 86:126\u2013145","journal-title":"Acta Ophthalmol"},{"key":"1307_CR29","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","volume":"87","author":"WM Chan","year":"2003","unstructured":"Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87:1453\u20131458","journal-title":"Br J Ophthalmol"},{"key":"1307_CR30","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0002-9394(03)00462-8","volume":"136","author":"WM Chan","year":"2003","unstructured":"Chan WM, Lam DS, Lai TY, Yuen KS, Liu DT, Chan CK, Chen WQ (2003) Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol 136:836\u2013845","journal-title":"Am J Ophthalmol"},{"key":"1307_CR31","first-page":"448","volume":"24","author":"F Bandello","year":"2001","unstructured":"Bandello F, Virgili G, Lanzetta P, Pirracchio A, Menchini U (2001) ICG angiography and retinal pigment epithelial decompensation (CRSC and epitheliopathy). J Fr Ophtalmol 24:448\u2013451","journal-title":"J Fr Ophtalmol"},{"key":"1307_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0002-9394(00)00395-0","volume":"130","author":"BA Cooper","year":"2000","unstructured":"Cooper BA, Thomas MA (2000) Submacular surgery to remove choroidal neovascularization associated with central serous chorioretinopathy. Am J Ophthalmol 130:187\u2013191","journal-title":"Am J Ophthalmol"},{"key":"1307_CR33","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/bjo.2006.090282","volume":"90","author":"TY Lai","year":"2006","unstructured":"Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS (2006) Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 90:869\u2013874","journal-title":"Br J Ophthalmol"},{"key":"1307_CR34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/IAE.0b013e318156777f","volume":"28","author":"WM Chan","year":"2008","unstructured":"Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS (2008) Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 28:85\u201393","journal-title":"Retina"},{"key":"1307_CR35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archopht.122.1.37","volume":"122","author":"E Ergun","year":"2004","unstructured":"Ergun E, Tittl M, Stur M (2004) Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy. Arch Ophthalmol 122:37\u201341","journal-title":"Arch Ophthalmol"},{"key":"1307_CR36","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ophtha.2005.06.026","volume":"112","author":"MD Ober","year":"2005","unstructured":"Ober MD, Yannuzzi LA, Do DV, Spaide RF, Bressler NM, Jampol LM, Angelilli A, Eandi CM, Lyon AT (2005) Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology 112:2088\u20132094","journal-title":"Ophthalmology"},{"key":"1307_CR37","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00417-009-1104-8","volume":"247","author":"JW Moon","year":"2009","unstructured":"Moon JW, Yu HG, Kim TW, Kim HC, Chung H (2009) Prognostic factors related to photodynamic therapy for central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 247:1315\u20131323","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1307_CR38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000210386","volume":"223","author":"E Ozmert","year":"2009","unstructured":"Ozmert E, Batioglu F (2009) Fundus autofluorescence before and after photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmologica 223:263\u2013268","journal-title":"Ophthalmologica"},{"key":"1307_CR39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/lsm.20720","volume":"40","author":"RM Tarantola","year":"2008","unstructured":"Tarantola RM, Law JC, Recchia FM, Sternberg P Jr, Agarwal A (2008) Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy. Lasers Surg Med 40:671\u2013675","journal-title":"Lasers Surg Med"},{"key":"1307_CR40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10384-008-0613-z","volume":"53","author":"PY Lee","year":"2009","unstructured":"Lee PY, Kim KS, Lee WK (2009) Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy. Jpn J Ophthalmol 53:52\u201356","journal-title":"Jpn J Ophthalmol"},{"key":"1307_CR41","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","volume":"115","author":"WM Chan","year":"2008","unstructured":"Chan WM, Lai TY, Lai RY, Liu DT, Lam DS (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115:1756\u20131765","journal-title":"Ophthalmology"},{"key":"1307_CR42","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/IAE.0b013e3181a6c028","volume":"29","author":"MW Zhao","year":"2009","unstructured":"Zhao MW, Zhou P, Xiao HX, Lv YS, Li CA, Liu GD, Li XX (2009) Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin. Retina 29:1155\u20131161","journal-title":"Retina"},{"key":"1307_CR43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.eye.6700597","volume":"18","author":"M Gupta","year":"2004","unstructured":"Gupta M, Singh AD, Rundle PA, Rennie IG (2004) Efficacy of photodynamic therapy in circumscribed choroidal haemangioma. Eye 18:139\u2013142","journal-title":"Eye"},{"key":"1307_CR44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-6257(00)00158-2","volume":"45","author":"U Schmidt-Erfurth","year":"2000","unstructured":"Schmidt-Erfurth U, Hasan T (2000) Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol 45:195\u2013214","journal-title":"Surv Ophthalmol"},{"key":"1307_CR45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0161-6420(13)31242-1","volume":"101","author":"U Schmidt-Erfurth","year":"1994","unstructured":"Schmidt-Erfurth U, Bauman W, Gragoudas E, Flotte TJ, Michaud NA, Birngruber R, Hasan T (1994) Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology 101:89\u201399","journal-title":"Ophthalmology"},{"key":"1307_CR46","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0181-5512(06)73889-X","volume":"29","author":"AP Guagnini","year":"2006","unstructured":"Guagnini AP, De Potter P, Levecq L (2006) Photodynamic therapy of circumscribed choroidal hemangiomas. J Fr Ophtalmol 29:1013\u20131017","journal-title":"J Fr Ophtalmol"},{"key":"1307_CR47","first-page":"1085","volume":"43","author":"Y Xiong","year":"2007","unstructured":"Xiong Y, Zhang F (2007) Photodynamic therapy for circumscribed choroidal hemangioma. Zhonghua Yan Ke Za Zhi 43:1085\u20131088","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"1307_CR48","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00006982-200509000-00003","volume":"25","author":"S Michels","year":"2005","unstructured":"Michels S, Michels R, Simader C, Schmidt-Erfurth U (2005) Verteporfin therapy for choroidal hemangioma: a long-term follow-up. Retina 25:697\u2013703","journal-title":"Retina"},{"key":"1307_CR49","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00417-003-0765-y","volume":"241","author":"FD Verbraak","year":"2003","unstructured":"Verbraak FD, Schlingemann RO, Keunen JE, de Smet MD (2003) Longstanding symptomatic choroidal hemangioma managed with limited PDT as initial or salvage therapy. Graefes Arch Clin Exp Ophthalmol 241:891\u2013898","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1307_CR50","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/bjo.87.1.84","volume":"87","author":"B Jurklies","year":"2003","unstructured":"Jurklies B, Anastassiou G, Ortmans S, Schuler A, Schilling H, Schmidt-Erfurth U, Bornfeld N (2003) Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma. Br J Ophthalmol 87:84\u201389","journal-title":"Br J Ophthalmol"},{"key":"1307_CR51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00417-004-1102-9","volume":"243","author":"EA Huiskamp","year":"2005","unstructured":"Huiskamp EA, Muskens RP, Ballast A, Hooymans JM (2005) Diffuse choroidal haemangioma in Sturge-Weber syndrome treated with photodynamic therapy under general anaesthesia. Graefes Arch Clin Exp Ophthalmol 243:727\u2013730","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1307_CR52","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0161-6420(02)01454-9","volume":"109","author":"UM Schmidt-Erfurth","year":"2002","unstructured":"Schmidt-Erfurth UM, Michels S, Kusserow C, Jurklies B, Augustin AJ (2002) Photodynamic therapy for symptomatic choroidal hemangioma: visual and anatomic results. Ophthalmology 109:2284\u20132294","journal-title":"Ophthalmology"},{"key":"1307_CR53","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ophtha.2008.08.029","volume":"116","author":"A Boixadera","year":"2009","unstructured":"Boixadera A, Garcia-Arumi J, Martinez-Castillo V, Encinas JL, Elizalde J, Blanco-Mateos G, Caminal J, Capeans C, Armada F, Navea A, Olea JL (2009) Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma. Ophthalmology 116:100\u2013105","journal-title":"Ophthalmology"},{"key":"1307_CR54","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/OPX.0b013e318196a724","volume":"86","author":"S Huang","year":"2009","unstructured":"Huang S, Fabian J, Murray T, Shi W (2009) Symptomatic circumscribed choroidal hemangioma undergoing PDT: VA outcomes. Optom Vis Sci 86:286\u2013289","journal-title":"Optom Vis Sci"},{"key":"1307_CR55","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0161-6420(02)01968-1","volume":"110","author":"G Porrini","year":"2003","unstructured":"Porrini G, Giovannini A, Amato G, Ioni A, Pantanetti M (2003) Photodynamic therapy of circumscribed choroidal hemangioma. Ophthalmology 110:674\u2013680","journal-title":"Ophthalmology"},{"key":"1307_CR56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3341\/kjo.2009.23.2.127","volume":"23","author":"M Sagong","year":"2009","unstructured":"Sagong M, Lee J, Chang W (2009) Application of intravitreal bevacizumab for circumscribed choroidal hemangioma. Korean J Ophthalmol 23:127\u2013131","journal-title":"Korean J Ophthalmol"},{"key":"1307_CR57","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0002-9394(03)00423-9","volume":"136","author":"R Anand","year":"2003","unstructured":"Anand R (2003) Photodynamic therapy for diffuse choroidal hemangioma associated with Sturge Weber syndrome. Am J Ophthalmol 136:758\u2013760","journal-title":"Am J Ophthalmol"},{"key":"1307_CR58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3341\/kjo.2007.21.3.142","volume":"21","author":"JM Lee","year":"2007","unstructured":"Lee JM, Nam WH, Kim HK (2007) Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks. Korean J Ophthalmol 21:142\u2013145","journal-title":"Korean J Ophthalmol"},{"key":"1307_CR59","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00006982-200410000-00013","volume":"24","author":"U Menchini","year":"2004","unstructured":"Menchini U, Virgili G, Introini U, Bandello F, Ambesi-Impiombato M, Pece A, Parodi MB, Giacomelli G, Capobianco B, Varano M, Brancato R (2004) Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy. Retina 24:763\u2013771","journal-title":"Retina"},{"key":"1307_CR60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00006982-198101020-00001","volume":"1","author":"LJ Singerman","year":"1981","unstructured":"Singerman LJ, Hatem G (1981) Laser treatment of choroidal neovascular membranes in angioid streaks. Retina 1:75\u201383","journal-title":"Retina"},{"key":"1307_CR61","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00417-005-0131-3","volume":"244","author":"L Arias","year":"2006","unstructured":"Arias L, Pujol O, Rubio M, Caminal J (2006) Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks. Graefes Arch Clin Exp Ophthalmol 244:753\u2013757","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1307_CR62","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ophtha.2005.02.011","volume":"112","author":"AC Browning","year":"2005","unstructured":"Browning AC, Chung AK, Ghanchi F, Harding SP, Musadiq M, Talks SJ, Yang YC, Amoaku WM (2005) Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series. Ophthalmology 112:1227\u20131231","journal-title":"Ophthalmology"},{"key":"1307_CR63","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00417-005-1193-y","volume":"243","author":"H Heimann","year":"2005","unstructured":"Heimann H, Gelisken F, Wachtlin J, Wehner A, Volker M, Foerster MH, Bartz-Schmidt KU (2005) Photodynamic therapy with verteporfin for choroidal neovascularization associated with angioid streaks. Graefes Arch Clin Exp Ophthalmol 243:1115\u20131123","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1307_CR64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000093071","volume":"38","author":"B Jurklies","year":"2006","unstructured":"Jurklies B, Bornfeld N, Schilling H (2006) Photodynamic therapy using verteporfin for choroidal neovascularization associated with angioid streaks\u2014long-term effects. Ophthalmic Res 38:209\u2013217","journal-title":"Ophthalmic Res"},{"key":"1307_CR65","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0002-9394(02)01626-4","volume":"134","author":"M Karacorlu","year":"2002","unstructured":"Karacorlu M, Karacorlu S, Ozdemir H, Mat C (2002) Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 134:360\u2013366","journal-title":"Am J Ophthalmol"},{"key":"1307_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(02)01835-4","volume":"135","author":"S Shaikh","year":"2003","unstructured":"Shaikh S, Ruby AJ, Williams GA (2003) Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks. Am J Ophthalmol 135:1\u20136","journal-title":"Am J Ophthalmol"},{"key":"1307_CR67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004397-200004000-00009","volume":"40","author":"IC Kuo","year":"2000","unstructured":"Kuo IC, Cunningham ET Jr (2000) Ocular neovascularization in patients with uveitis. Int Ophthalmol Clin 40:111\u2013126","journal-title":"Int Ophthalmol Clin"},{"key":"1307_CR68","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0161-6420(96)30561-7","volume":"103","author":"J Brown Jr","year":"1996","unstructured":"Brown J Jr, Folk JC, Reddy CV, Kimura AE (1996) Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 103:1100\u20131105","journal-title":"Ophthalmology"},{"key":"1307_CR69","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajo.2008.05.024","volume":"146","author":"AM Mansour","year":"2008","unstructured":"Mansour AM, Mackensen F, Arevalo JF, Ziemssen F, Mahendradas P, Mehio-Sibai A, Hrisomalos N, Lai TY, Dodwell D, Chan WM, Ness T, Banker AS, Pai SA, Berrocal MH, Tohme R, Heiligenhaus A, Bashshur ZF, Khairallah M, Salem KM, Hrisomalos FN, Wood MH, Heriot W, Adan A, Kumar A, Lim L, Hall A, Becker M (2008) Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol 146:410\u2013416","journal-title":"Am J Ophthalmol"},{"key":"1307_CR70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/IAE.0b013e318187aff9","volume":"29","author":"HF Fine","year":"2009","unstructured":"Fine HF, Zhitomirsky I, Freund KB, Barile GR, Shirkey BL, Samson CM, Yannuzzi LA (2009) Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis. Retina 29:8\u201312","journal-title":"Retina"},{"key":"1307_CR71","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00417-008-0906-4","volume":"246","author":"TH Tran","year":"2008","unstructured":"Tran TH, Fardeau C, Terrada C, Ducos DL, Bodaghi B, Lehoang P (2008) Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis. Graefes Arch Clin Exp Ophthalmol 246:1685\u20131692","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1307_CR72","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/IAE.0b013e31815e9834","volume":"27","author":"A Adan","year":"2007","unstructured":"Adan A, Mateo C, Navarro R, Bitrian E, Casaroli-Marano RP (2007) Intravitreal bevacizumab (avastin) injection as primary treatment of inflammatory choroidal neovascularization. Retina 27:1180\u20131186","journal-title":"Retina"},{"key":"1307_CR73","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ajo.2007.02.039","volume":"143","author":"WM Chan","year":"2007","unstructured":"Chan WM, Lai TY, Liu DT, Lam DS (2007) Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 143:977\u2013983","journal-title":"Am J Ophthalmol"},{"key":"1307_CR74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/09273940601174020","volume":"15","author":"RM Coco","year":"2007","unstructured":"Coco RM, de Souza CF, Sanabria MR (2007) Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy. Ocul Immunol Inflamm 15:27\u201329","journal-title":"Ocul Immunol Inflamm"},{"key":"1307_CR75","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/09273940590951124","volume":"13","author":"L Postelmans","year":"2005","unstructured":"Postelmans L, Pasteels B, Coquelet P, Caspers L, Verougstraete C, Leys A, Wirix M, Mauget-Faysse M, Quanranta M, Snyers B, Smets E (2005) Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like). Ocul Immunol Inflamm 13:361\u2013366","journal-title":"Ocul Immunol Inflamm"},{"key":"1307_CR76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/112067210601600118","volume":"16","author":"C Gerth","year":"2006","unstructured":"Gerth C, Spital G, Lommatzsch A, Heiligenhaus A, Pauleikhoff D (2006) Photodynamic therapy for choroidal neovascularization in patients with multifocal choroiditis and panuveitis. Eur J Ophthalmol 16:111\u2013118","journal-title":"Eur J Ophthalmol"},{"key":"1307_CR77","doi-asserted-by":"crossref","first-page":"198","DOI":"10.47102\/annals-acadmedsg.V35N3p198","volume":"35","author":"JI Lim","year":"2006","unstructured":"Lim JI, Flaxel CJ, LaBree L (2006) Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease. Ann Acad Med Singapore 35:198\u2013202","journal-title":"Ann Acad Med Singapore"},{"key":"1307_CR78","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.iae.0000238552.76412.ae","volume":"26","author":"M Mauget-Faysse","year":"2006","unstructured":"Mauget-Faysse M, Mimoun G, Ruiz-Moreno JM, Quaranta-El Maftouhi M, De Laey JJ, Postelmans L, Soubrane G, Defauchy M, Leys A (2006) Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis. Retina 26:396\u2013403","journal-title":"Retina"},{"key":"1307_CR79","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ajo.2005.07.045","volume":"141","author":"MB Parodi","year":"2006","unstructured":"Parodi MB, Iacono P, Spasse S, Ravalico G (2006) Photodynamic therapy for juxtafoveal choroidal neovascularization associated with multifocal choroiditis. Am J Ophthalmol 141:123\u2013128","journal-title":"Am J Ophthalmol"},{"key":"1307_CR80","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00006982-200210000-00003","volume":"22","author":"RF Spaide","year":"2002","unstructured":"Spaide RF, Freund KB, Slakter J, Sorenson J, Yannuzzi LA, Fisher Y (2002) Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina 22:545\u2013549","journal-title":"Retina"},{"key":"1307_CR81","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00417-003-0734-5","volume":"241","author":"J Wachtlin","year":"2003","unstructured":"Wachtlin J, Heimann H, Behme T, Foerster MH (2003) Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol 241:899\u2013906","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1307_CR82","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ajo.2004.03.029","volume":"138","author":"MB Parodi","year":"2004","unstructured":"Parodi MB, Di CL, Lanzetta P, Polito A, Bandello F, Ravalico G (2004) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization associated with multifocal choroiditis. Am J Ophthalmol 138:263\u2013269","journal-title":"Am J Ophthalmol"},{"key":"1307_CR83","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/bjo.2004.063024","volume":"89","author":"A Hogan","year":"2005","unstructured":"Hogan A, Behan U, Kilmartin DJ (2005) Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation. Br J Ophthalmol 89:1109\u20131111","journal-title":"Br J Ophthalmol"},{"key":"1307_CR84","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group","year":"1999","unstructured":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials\u2014TAP report. Arch Ophthalmol 117:1329\u20131345","journal-title":"Arch Ophthalmol"},{"key":"1307_CR85","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ajo.2004.06.033","volume":"138","author":"L Postelmans","year":"2004","unstructured":"Postelmans L, Pasteels B, Coquelet P, El Ouardighi H, Verougstraete C, Schmidt-Erfurth U (2004) Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females. Am J Ophthalmol 138:803\u2013808","journal-title":"Am J Ophthalmol"},{"key":"1307_CR86","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00417-003-0650-8","volume":"241","author":"J Wachtlin","year":"2003","unstructured":"Wachtlin J, Behme T, Heimann H, Kellner U, Foerster MH (2003) Concentric retinal pigment epithelium atrophy after a single photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 241:518\u2013521","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1307_CR87","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0420.2006.00738.x","volume":"85","author":"MB Parodi","year":"2007","unstructured":"Parodi MB, Da Pozzo S, Ravalico G (2007) Retinal pigment epithelium changes after photodynamic therapy for choroidal neovascularization in pathological myopia. Acta Ophthalmol Scand 85:50\u201354","journal-title":"Acta Ophthalmol Scand"},{"key":"1307_CR88","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000221837","volume":"223","author":"S Honda","year":"2009","unstructured":"Honda S, Imai H, Yamashiro K, Kurimoto Y, Kanamori-Matsui N, Kagotani Y, Tamura Y, Yamamoto H, Ohoto S, Takagi H, Uenishi M, Negi A (2009) Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan. Ophthalmologica 223:333\u2013338","journal-title":"Ophthalmologica"},{"key":"1307_CR89","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1442-9071.2005.01105.x","volume":"33","author":"WM Chan","year":"2005","unstructured":"Chan WM, Liu DT, Lai TY, Li H, Tong JP, Lam DS (2005) Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up. Clin Experiment Ophthalmol 33:611\u2013618","journal-title":"Clin Experiment Ophthalmol"},{"key":"1307_CR90","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/0301-4738.16172","volume":"53","author":"N Hussain","year":"2005","unstructured":"Hussain N, Hussain A, Natarajan S (2005) Role of photodynamic therapy in polypoidal choroidal vasculopathy. Indian J Ophthalmol 53:101\u2013104","journal-title":"Indian J Ophthalmol"},{"key":"1307_CR91","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/112067210601600506","volume":"16","author":"M Mauget-Faysse","year":"2006","unstructured":"Mauget-Faysse M, Quaranta-El Maftouhi M, De La ME, Leys A (2006) Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy. Eur J Ophthalmol 16:695\u2013704","journal-title":"Eur J Ophthalmol"},{"key":"1307_CR92","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10384-007-0436-3","volume":"51","author":"T Ogino","year":"2007","unstructured":"Ogino T, Takeda M, Imaizumi H, Okushiba U (2007) Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year. Jpn J Ophthalmol 51:210\u2013215","journal-title":"Jpn J Ophthalmol"},{"key":"1307_CR93","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9394(02)01516-7","volume":"134","author":"M Quaranta","year":"2002","unstructured":"Quaranta M, Mauget-Faysse M, Coscas G (2002) Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Am J Ophthalmol 134:277\u2013280","journal-title":"Am J Ophthalmol"},{"key":"1307_CR94","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00417-007-0582-9","volume":"245","author":"K Sayanagi","year":"2007","unstructured":"Sayanagi K, Gomi F, Sawa M, Ohji M, Tano Y (2007) Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 245:1569\u20131571","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1307_CR95","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3341\/kjo.2008.22.2.92","volume":"22","author":"SY Lee","year":"2008","unstructured":"Lee SY, Kim JG, Joe SG, Chung H, Yoon YH (2008) The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy. Korean J Ophthalmol 22:92\u201399","journal-title":"Korean J Ophthalmol"},{"key":"1307_CR96","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/bjo.2004.044396","volume":"88","author":"AD Singh","year":"2004","unstructured":"Singh AD, Kaiser PK, Sears JE, Gupta M, Rundle PA, Rennie IG (2004) Photodynamic therapy of circumscribed choroidal haemangioma. Br J Ophthalmol 88:1414\u20131418","journal-title":"Br J Ophthalmol"},{"key":"1307_CR97","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1034\/j.1600-0420.2002.800513.x","volume":"80","author":"IM Landau","year":"2002","unstructured":"Landau IM, Steen B, Seregard S (2002) Photodynamic therapy for circumscribed choroidal haemangioma. Acta Ophthalmol Scand 80:531\u2013536","journal-title":"Acta Ophthalmol Scand"},{"key":"1307_CR98","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/112067210501500111","volume":"15","author":"ID Ladas","year":"2005","unstructured":"Ladas ID, Georgalas I, Rouvas AA, Gotsis S, Karagiannis DA, Moschos M (2005) Photodynamic therapy with verteporfin of choroidal neovascularization in angioid streaks: conventional versus early retreatment. Eur J Ophthalmol 15:69\u201373","journal-title":"Eur J Ophthalmol"},{"key":"1307_CR99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/IAE.0b013e31815e9339","volume":"28","author":"WM Chan","year":"2008","unstructured":"Chan WM, Lai TY, Lau TT, Lee VY, Liu DT, Lam DS (2008) Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series. Retina 28:71\u201380","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1307-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-010-1307-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1307-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T07:40:00Z","timestamp":1685432400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-010-1307-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,17]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["1307"],"URL":"https:\/\/doi.org\/10.1007\/s00417-010-1307-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,17]]}}}